We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the

  • jump to the main content
  • jump to the bottom of the page
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
  • News
  • Podcasts
  • Activities
  • Location and contact
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
  • Assistance and health
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Guide for patients and companions
    • Assistive Devices
  • Research
    • Home
    • About research
    • Research areas
    • Core Facilities
    • Work at Idibaps
  • Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • About the Clinic
Search
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
  • News
  • Podcasts
  • Activities
  • Location and contact
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
Navigation thread
  • Home
  • Organizational structure
  • The Biomedical Diagnostic Center
  • News
  • The Biomedical Diagnostic Center

News from The Biomedical Diagnostic Center

February 17 2022 2022-02-18

A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma

A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1

January 25 2022 2022-01-25

Developed the first genomic test for personalized HER2+ breast cancer treatments

The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.

October 6 2021 2021-10-13

It has been shown that COVID-19 can damage the placenta in pregnant women

Researchers from the CLÍNIC-IDIBAPS, the Hospital Universitari Vall d’Hebron and the Parc Taulí de Sabadell have shown the damage caused by the SARS-1

July 1 2021 2021-07-16

Dr. Manel Juan:" “There are no good vaccines or bad vaccines”

Interview with Dr. Manel Juan, head of the Immunology Service

February 10 2021 2021-03-08

AEMPS authorises Hospital Clínic's CAR-T ARI-0001 for patients with acute lymphoblastic leukaemia

The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug o1

October 30 2020 2020-11-02

Can you be protected against COVID-19 without antibodies?

In just a few months, the coronavirus has gone from being completely unknown to being the focus of countless scientific investigations around the wor1

October 13 2020 2020-10-13

Immuneel Therapeutics, Hospital Clínic de Barcelona & IDIBAPS Announce a Strategic collaboration & a License Agreement

Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Ho1

June 10 2020 2020-06-11

A consortium of European hospitals led by Clínic IDIBAPS is launching a cellular immunotherapy project to tackle COVID-19 with the support of Cellnex Telecom

Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1

May 26 2020 2020-05-26

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures

Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating h1

December 4 2019 2019-12-04

Liver fibrosis could be treated with gold nanoparticles

Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.

navigation between pages below

Next page
  • page1 , current page.
  • page2
  • page3
Next page

Subscribe to the Newsletter of Clínic

Receive the latest news from our institution directly to your email.

Thanks for your subscription!

We have received your information. Check your inbox, in a few moments you will receive a confirmation email.

An error has occurred and we have not been able to send your data, please try again later.
  • Assistance and health
    Assistance and health
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Guide for patients and companions
  • Research
    Research
    • Home
    • About research
    • Research areas
    • Core Facilities
  • Teaching
    Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
  • Cookies policy
  • Profile of the contracting party
  • Legal Notice
  • Data protection
  • Transparency portal
  • Privacy policy
© 2022